A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreatic Ductal Adenocarcinoma Treated With MEK Inhibitor-based Combination Therapy
Clinical trial NCT05630989 · RECRUITING
Trial details
- NCT number
- NCT05630989
- Sponsor
- Mandana Kamgar, MD
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-02-07
- Primary completion
- 2027-08-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.